tiprankstipranks
Trending News
More News >
Rocket Pharma (RCKT)
NASDAQ:RCKT
US Market

Rocket Pharmaceuticals (RCKT) Income Statement

Compare
1,665 Followers

Rocket Pharmaceuticals Income Statement

Last quarter (Q3 2025), Rocket Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Rocket Pharmaceuticals's net income was $-50.33M. See Rocket Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -1.15M
Operating Expenses
$ 273.20M$ 259.66M$ 224.34M$ 167.25M$ 134.86M
Depreciation and Amortization
$ 9.38M$ 7.10M$ 6.27M$ 5.37M$ 1.15M
EBITDA
$ -247.49M$ -236.62M$ -213.69M$ -157.81M$ -131.59M
Operating Income
$ -273.20M$ -259.66M$ -224.34M$ -167.25M$ -136.00M
Other Income/Expenses
$ 14.46M$ 14.06M$ 2.48M$ -1.82M$ -3.70M
Pretax Income
$ -258.75M$ -245.59M$ -221.86M$ -169.07M$ -139.70M
Net Income
$ -258.75M$ -245.59M$ -221.86M$ -169.07M$ -146.67M
Per Share Metrics
Basic EPS
$ -2.73$ -2.92$ -3.26$ -2.68$ -2.52
Diluted EPS
$ -2.73$ -2.92$ -3.26$ -2.68$ -2.52
Weighted Average Shares Outstanding
94.81M 84.01M 68.15M 63.24M 55.38M
Weighted Average Shares Outstanding (Diluted)
94.81M 84.01M 68.15M 63.24M 55.38M
Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History